The antiretroviral therapy coverage for adult women living with HIV in Malaysia showed a steady increase from 33 units in 2013 to 78 units in 2023. The data indicates a growth pattern, with annual variations stabilizing over the years. Between 2021 and 2023, the year-on-year increase averaged around 4%, demonstrating a deceleration in growth compared to previous years. The 5-year Compound Annual Growth Rate (CAGR) up to 2023 stood at 4.7%, indicating consistent progress in the treatment coverage.
Future trends point toward a moderated growth rate, with the forecasted 5-year CAGR from 2024 to 2028 at 2.58%, reaching 92 units in 2028. This suggests a gradual tapering in the expansion rate, emphasizing the need for sustained investment and innovative strategies to continue improving coverage. Key trends to monitor include policy changes, funding allocations, and advancements in HIV treatment and prevention technologies.
